Kang, Hyunkoo
Lee, Sungmin
Kim, Kyeongmin
Jeon, Jaewan
Kang, Seok-Gu
Youn, HyeSook
Kim, Hae Yu
Youn, BuHyun
Article History
Received: 9 June 2021
Accepted: 17 August 2021
First Online: 6 September 2021
Declarations
:
: The study protocol of patient-derived glioblastoma stem cells was approved by the Institutional Review Board of Haeundae Paik Hospital (IRB No. HPIRB-2017-06-007-004) and Severance Hospital (IRB No. 4–2012-0212). The animal protocol used in this study was approved by the Pusan National University Institutional Animal Care and Use Committee (PNU-IACUC) for ethical procedures and scientific care (Approval Number PNU-2020-2809).
: All co-authors have read and approved of its submission to this journal.
: The authors declare no conflict of interest.